SYRE

SYRE

USD

Spyre Therapeutics Inc. Common Stock

$22.520+0.640 (2.925%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$21.880

Hoch

$22.540

Tief

$21.150

Volumen

0.80M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.7B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.83M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $10.91Aktuell $22.520Hoch $40.26

Ähnliche Nachrichten

GlobeNewswire

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual

Mehr anzeigen
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Spyre Therapeutics to Participate in Upcoming November Investor Conferences

WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of

Mehr anzeigen
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
GlobeNewswire

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of

Mehr anzeigen
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.